TAP
35
4
PNC
59
3
DG
57
7
ORLY
58
8
SWK
46
-3
TRV
42
5
KO
47
3
ESS
33
2
COST
53
2
VTR
63
6
BSX
42
2
NTAP
46
3
CCI
39
9
JCI
51
-3
CAT
55
-2
UNP
50
2
PH
60
-2
FOX
26
-2
GE
55
-5
PCG
54
-4
TAP
35
4
PNC
59
3
DG
57
7
ORLY
58
8
SWK
46
-3
TRV
42
5
KO
47
3
ESS
33
2
COST
53
2
VTR
63
6
BSX
42
2
NTAP
46
3
CCI
39
9
JCI
51
-3
CAT
55
-2
UNP
50
2
PH
60
-2
FOX
26
-2
GE
55
-5
PCG
54
-4
Financhill
Back

Biodexa Pharmaceuticals Plc 10K Form

Sell
36

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
$0.89
Seasonality Move:
-19.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.41

Profitability

EPS (TTM): -20.78950
Net Income (TTM): $-8.4M
Gross Margin: $-249.1K
Return on Equity: -160.77%
Return on Assets: -87.8%

Biodexa Pharmaceuticals Plc Earnings Forecast

Key Biodexa Pharmaceuticals Plc Financial Ratios

  • Per Share Earnings over the last 14 years have been positive in 7 years.

Biodexa Pharmaceuticals Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.26
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
36
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Is Biodexa Pharmaceuticals Plc a Buy or a Sell?